SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
Volker Vallon(Unknown), Timo Rieg(University of South Florida), Joseph Satriano(University of California San Diego), Maria Gerasimova(VA San Diego Healthcare System), Takahiro Masuda(Jichi Medical University), Hermann Koepsell(University of Würzburg), Eric Mayoux(Boehringer Ingelheim (Germany)), Michael Rose(VA San Diego Healthcare System), Scott C. Thomson(UC San Diego Health System)
Cited by 481
Related Papers
Glucose transporters in brain in health and disease
|Pflügers Archiv - European Journal of Physiology|2020|520
Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5
|Journal of Clinical Investigation|2003|432
Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5
|Journal of Clinical Investigation|2003|404
Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia
|American Journal of Physiology-Renal Physiology|2013|308
SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy
|Journal of Biological Chemistry|2017|302